₹ 2,016.50
7.70 (0.38%)
L
Dr. Lal Path Labs
₹ 2,016.50
Dr. Lal Path Labs EPS Summary (consolidated)
The latest quarterly EPS of Dr. Lal Path Labs as of Q2 Sep 2026 stands at ₹11.51. This is a 13.40% growth quarter on quarter and 36.23% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹10.79. It beat the estimate by ₹0.72. For the FY2026 the EPS of Dr. Lal Path Labs stands at ₹30.24. This is a 3.42% growth compared with FY2025.
Dr. Lal Path Labs EPS
EPS by Peers

A
Apollo Hospitals

M
Max Healthcare Institute

A
Aster DM Quality Care

F
Fortis Healthcare

N
Narayana Hrudayalaya
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

